Published in AIDS Weekly, December 3rd, 2001
"Viread addresses many of the needs of people living with HIV today. The drug has demonstrated a significant antiviral response, even in patients who may no longer respond well to available therapies due to the development of viral...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.